SM
Sabby Management’s Theriva Biologics TOVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-76,896
| Closed | -$25K | – | 80 |
|
|
2020
Q1 | $25K | Sell |
76,896
-610,408
| -89% | -$198K | 0.01% | 51 |
|
|
2019
Q4 | $348K | Sell |
687,304
-148,155
| -18% | -$75K | 0.1% | 22 |
|
|
2019
Q3 | $379K | Sell |
835,459
-68,282
| -8% | -$31K | 0.2% | 34 |
|
|
2019
Q2 | $497K | Buy |
903,741
+218,815
| +32% | +$120K | 0.62% | 23 |
|
|
2019
Q1 | $465K | Sell |
684,926
-432,533
| -39% | -$294K | 0.22% | 21 |
|
|
2018
Q4 | $626K | Buy |
+1,117,459
| New | +$626K | 0.14% | 24 |
|
|
2017
Q3 | – | Sell |
-168,401
| Closed | -$95K | – | 134 |
|
|
2017
Q2 | $95K | Sell |
168,401
-1,245,810
| -88% | -$703K | 0.01% | 97 |
|
|
2017
Q1 | $892K | Sell |
1,414,211
-1,617,742
| -53% | -$1.02M | 0.05% | 50 |
|
|
2016
Q4 | $2.31M | Buy |
+3,031,953
| New | +$2.31M | 0.13% | 20 |
|